Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

Abstract Background Gastric cancer (GC) is a globally prevalent cancer, ranking fifth for incidence and fourth for mortality worldwide. The N6-methyladenosine (m6A) related long noncoding RNAs (lncRNAs) were widely investigated in recent studies. Nevertheless, the underlying prognostic implication a...

Full description

Bibliographic Details
Main Authors: Tenghui Han, Dong Xu, Jun Zhu, Jipeng Li, Lei Liu, Yanchun Deng
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Cancer Cell International
Subjects:
m6A modification
Gastric cancer
Immune checkpoint blockers
LncRNA
FTO
Online Access:https://doi.org/10.1186/s12935-021-02146-w

Internet

https://doi.org/10.1186/s12935-021-02146-w

Similar Items